Global and United States Thalassemia Market Report & Forecast 2023-2028

Report ID: 1835137 | Published Date: Jan 2025 | No. of Page: 85 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Thalassemia Revenue in Thalassemia Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Thalassemia Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Thalassemia Market Size for the Year 2017-2028
        1.2.2 Global Thalassemia Market Size for the Year 2017-2028
    1.3 Thalassemia Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Thalassemia in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Thalassemia Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Thalassemia Market Dynamics
        1.4.1 Thalassemia Industry Trends
        1.4.2 Thalassemia Market Drivers
        1.4.3 Thalassemia Market Challenges
        1.4.4 Thalassemia Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Thalassemia by Type
    2.1 Thalassemia Market Segment by Type
        2.1.1 Iron Chelating Drugs
        2.1.2 Others
    2.2 Global Thalassemia Market Size by Type (2017, 2022 & 2028)
    2.3 Global Thalassemia Market Size by Type (2017-2028)
    2.4 United States Thalassemia Market Size by Type (2017, 2022 & 2028)
    2.5 United States Thalassemia Market Size by Type (2017-2028)
3 Thalassemia by Application
    3.1 Thalassemia Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinic
        3.1.3 Research Institute
        3.1.4 Laboratories
        3.1.5 Others
    3.2 Global Thalassemia Market Size by Application (2017, 2022 & 2028)
    3.3 Global Thalassemia Market Size by Application (2017-2028)
    3.4 United States Thalassemia Market Size by Application (2017, 2022 & 2028)
    3.5 United States Thalassemia Market Size by Application (2017-2028)
4 Global Thalassemia Competitor Landscape by Company
    4.1 Global Thalassemia Market Size by Company
        4.1.1 Top Global Thalassemia Companies Ranked by Revenue (2021)
        4.1.2 Global Thalassemia Revenue by Player (2017-2022)
    4.2 Global Thalassemia Concentration Ratio (CR)
        4.2.1 Thalassemia Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Thalassemia in 2021
        4.2.3 Global Thalassemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Thalassemia Headquarters, Revenue in Thalassemia Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Thalassemia Headquarters and Area Served
        4.3.2 Global Thalassemia Companies Revenue in Thalassemia Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Thalassemia Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Thalassemia Market Size by Company
        4.5.1 Top Thalassemia Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Thalassemia Revenue by Players (2020, 2021 & 2022)
5 Global Thalassemia Market Size by Region
    5.1 Global Thalassemia Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Thalassemia Market Size by Region (2017-2028)
        5.2.1 Global Thalassemia Market Size by Region: 2017-2022
        5.2.2 Global Thalassemia Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Thalassemia Market Size YoY Growth 2017-2028
        6.1.2 North America Thalassemia Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Thalassemia Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Thalassemia Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Thalassemia Market Size YoY Growth 2017-2028
        6.3.2 Europe Thalassemia Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Thalassemia Market Size YoY Growth 2017-2028
        6.4.2 Latin America Thalassemia Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Thalassemia Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Thalassemia Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Bluebird bio, Inc.
        7.1.1 Bluebird bio, Inc. Company Details
        7.1.2 Bluebird bio, Inc. Business Overview
        7.1.3 Bluebird bio, Inc. Thalassemia Introduction
        7.1.4 Bluebird bio, Inc. Revenue in Thalassemia Business (2017-2022)
        7.1.5 Bluebird bio, Inc. Recent Development
    7.2 Acceleron Pharma, Inc.
        7.2.1 Acceleron Pharma, Inc. Company Details
        7.2.2 Acceleron Pharma, Inc. Business Overview
        7.2.3 Acceleron Pharma, Inc. Thalassemia Introduction
        7.2.4 Acceleron Pharma, Inc. Revenue in Thalassemia Business (2017-2022)
        7.2.5 Acceleron Pharma, Inc. Recent Development
    7.3 Celgene Corporation
        7.3.1 Celgene Corporation Company Details
        7.3.2 Celgene Corporation Business Overview
        7.3.3 Celgene Corporation Thalassemia Introduction
        7.3.4 Celgene Corporation Revenue in Thalassemia Business (2017-2022)
        7.3.5 Celgene Corporation Recent Development
    7.4 GlaxoSmithKline plc
        7.4.1 GlaxoSmithKline plc Company Details
        7.4.2 GlaxoSmithKline plc Business Overview
        7.4.3 GlaxoSmithKline plc Thalassemia Introduction
        7.4.4 GlaxoSmithKline plc Revenue in Thalassemia Business (2017-2022)
        7.4.5 GlaxoSmithKline plc Recent Development
    7.5 Incyte Corporation
        7.5.1 Incyte Corporation Company Details
        7.5.2 Incyte Corporation Business Overview
        7.5.3 Incyte Corporation Thalassemia Introduction
        7.5.4 Incyte Corporation Revenue in Thalassemia Business (2017-2022)
        7.5.5 Incyte Corporation Recent Development
    7.6 Gamida Cell
        7.6.1 Gamida Cell Company Details
        7.6.2 Gamida Cell Business Overview
        7.6.3 Gamida Cell Thalassemia Introduction
        7.6.4 Gamida Cell Revenue in Thalassemia Business (2017-2022)
        7.6.5 Gamida Cell Recent Development
    7.7 Kiadis Pharma
        7.7.1 Kiadis Pharma Company Details
        7.7.2 Kiadis Pharma Business Overview
        7.7.3 Kiadis Pharma Thalassemia Introduction
        7.7.4 Kiadis Pharma Revenue in Thalassemia Business (2017-2022)
        7.7.5 Kiadis Pharma Recent Development
    7.8 La Jolla Pharmaceutical Company
        7.8.1 La Jolla Pharmaceutical Company Company Details
        7.8.2 La Jolla Pharmaceutical Company Business Overview
        7.8.3 La Jolla Pharmaceutical Company Thalassemia Introduction
        7.8.4 La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2017-2022)
        7.8.5 La Jolla Pharmaceutical Company Recent Development
    7.9 IONIS Pharmaceuticals
        7.9.1 IONIS Pharmaceuticals Company Details
        7.9.2 IONIS Pharmaceuticals Business Overview
        7.9.3 IONIS Pharmaceuticals Thalassemia Introduction
        7.9.4 IONIS Pharmaceuticals Revenue in Thalassemia Business (2017-2022)
        7.9.5 IONIS Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Thalassemia Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Thalassemia Market Trends
    Table 3. Thalassemia Market Drivers
    Table 4. Thalassemia Market Challenges
    Table 5. Thalassemia Market Restraints
    Table 6. Global Thalassemia Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Thalassemia Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Thalassemia Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Thalassemia Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Thalassemia Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Thalassemia Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Thalassemia Revenue Share by Player, 2017-2022
    Table 13. Global Thalassemia Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Thalassemia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thalassemia as of 2021)
    Table 15. Top Players of Thalassemia in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Thalassemia Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Thalassemia Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Thalassemia Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Thalassemia Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Thalassemia Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Thalassemia Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Thalassemia Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Thalassemia Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Thalassemia Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Thalassemia Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Thalassemia Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Thalassemia Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Thalassemia Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Bluebird bio, Inc. Company Details
    Table 31. Bluebird bio, Inc. Business Overview
    Table 32. Bluebird bio, Inc. Thalassemia Product
    Table 33. Bluebird bio, Inc. Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 34. Bluebird bio, Inc. Recent Development
    Table 35. Acceleron Pharma, Inc. Company Details
    Table 36. Acceleron Pharma, Inc. Business Overview
    Table 37. Acceleron Pharma, Inc. Thalassemia Product
    Table 38. Acceleron Pharma, Inc. Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 39. Acceleron Pharma, Inc. Recent Development
    Table 40. Celgene Corporation Company Details
    Table 41. Celgene Corporation Business Overview
    Table 42. Celgene Corporation Thalassemia Product
    Table 43. Celgene Corporation Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 44. Celgene Corporation Recent Development
    Table 45. GlaxoSmithKline plc Company Details
    Table 46. GlaxoSmithKline plc Business Overview
    Table 47. GlaxoSmithKline plc Thalassemia Product
    Table 48. GlaxoSmithKline plc Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 49. GlaxoSmithKline plc Recent Development
    Table 50. Incyte Corporation Company Details
    Table 51. Incyte Corporation Business Overview
    Table 52. Incyte Corporation Thalassemia Product
    Table 53. Incyte Corporation Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 54. Incyte Corporation Recent Development
    Table 55. Gamida Cell Company Details
    Table 56. Gamida Cell Business Overview
    Table 57. Gamida Cell Thalassemia Product
    Table 58. Gamida Cell Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 59. Gamida Cell Recent Development
    Table 60. Kiadis Pharma Company Details
    Table 61. Kiadis Pharma Business Overview
    Table 62. Kiadis Pharma Thalassemia Product
    Table 63. Kiadis Pharma Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 64. Kiadis Pharma Recent Development
    Table 65. La Jolla Pharmaceutical Company Company Details
    Table 66. La Jolla Pharmaceutical Company Business Overview
    Table 67. La Jolla Pharmaceutical Company Thalassemia Product
    Table 68. La Jolla Pharmaceutical Company Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 69. La Jolla Pharmaceutical Company Recent Development
    Table 70. IONIS Pharmaceuticals Company Details
    Table 71. IONIS Pharmaceuticals Business Overview
    Table 72. IONIS Pharmaceuticals Thalassemia Product
    Table 73. IONIS Pharmaceuticals Revenue in Thalassemia Business (2017-2022) & (US$ Million)
    Table 74. IONIS Pharmaceuticals Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Thalassemia Product Picture
    Figure 2. Global Thalassemia Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Thalassemia Market Size 2017-2028 (US$ Million)
    Figure 4. United States Thalassemia Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Thalassemia Market Size 2017-2028 (US$ Million)
    Figure 6. United States Thalassemia Market Share in Global 2017-2028
    Figure 7. Thalassemia Report Years Considered
    Figure 8. Product Picture of Iron Chelating Drugs
    Figure 9. Product Picture of Others
    Figure 10. Global Thalassemia Market Share by Type in 2022 & 2028
    Figure 11. Global Thalassemia Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Thalassemia Market Share by Type (2017-2028)
    Figure 13. United States Thalassemia Market Share by Type in 2022 & 2028
    Figure 14. United States Thalassemia Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Thalassemia Market Share by Type (2017-2028)
    Figure 16. Product Picture of Hospital
    Figure 17. Product Picture of Clinic
    Figure 18. Product Picture of Research Institute
    Figure 19. Product Picture of Laboratories
    Figure 20. Product Picture of Others
    Figure 21. Global Thalassemia Market Share by Application in 2022 & 2028
    Figure 22. Global Thalassemia Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Thalassemia Market Share by Application (2017-2028)
    Figure 24. United States Thalassemia Market Share by Application in 2022 & 2028
    Figure 25. United States Thalassemia Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Thalassemia Market Share by Application (2017-2028)
    Figure 27. North America Thalassemia Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Thalassemia Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Thalassemia Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Thalassemia Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Thalassemia Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Thalassemia Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Bluebird bio, Inc. Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 56. Acceleron Pharma, Inc. Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 57. Celgene Corporation Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 58. GlaxoSmithKline plc Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 59. Incyte Corporation Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 60. Gamida Cell Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 61. Kiadis Pharma Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 62. La Jolla Pharmaceutical Company Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 63. IONIS Pharmaceuticals Revenue Growth Rate in Thalassemia Business (2017-2022)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bluebird bio, Inc.
Acceleron Pharma, Inc.
Celgene Corporation
GlaxoSmithKline plc
Incyte Corporation
Gamida Cell
Kiadis Pharma
La Jolla Pharmaceutical Company
IONIS Pharmaceuticals
Frequently Asked Questions
Thalassemia report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Thalassemia report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Thalassemia report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Research Antibodies

Research Antibodies market is segmented by region (country), players, by Type and by Application. ... Read More